PUMA BIOTECHNOLOGY, INC. Current State and Local Tax Expense (Benefit)
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Current State and Local Tax Expense (Benefit) of $1.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-26
- PUMA BIOTECHNOLOGY, INC. current state and local tax expense (benefit) for fiscal 2025 was $1.25M, a 72.71% increase from fiscal 2024.
- PUMA BIOTECHNOLOGY, INC. current state and local tax expense (benefit) for fiscal 2024 was $722.00K, a 20.22% decline from fiscal 2023.
- PUMA BIOTECHNOLOGY, INC. current state and local tax expense (benefit) for fiscal 2023 was $905.00K, a 149.31% increase from fiscal 2022.
- PUMA BIOTECHNOLOGY, INC. current state and local tax expense (benefit) for fiscal 2022 was $363.00K, a 371.43% increase from fiscal 2021.
| Period end | Current State and Local Tax Expense (Benefit) 12 month |
|---|---|
| 2025-12-31 | $1.25M 10-K · filed 2026-02-26 |
| 2024-12-31 | $722.00K 10-K · filed 2026-02-26 |
| 2023-12-31 | $905.00K 10-K · filed 2026-02-26 |
| 2022-12-31 | $363.00K 10-K · filed 2025-02-27 |
| 2021-12-31 | $77.00K 10-K · filed 2024-02-29 |
| 2020-12-31 | $124.00K 10-K · filed 2023-03-02 |
| 2019-12-31 | $53.00K 10-K · filed 2022-03-03 |
| 2018-12-31 | $17.00K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |